Role of magnesium sulfate in seizure prevention in patients with eclampsia and pre-eclampsia

Drug Safety

Volumn 15, Issue 3, 1996, Pages 188-199

  Anthony, John ^a   Johanson, Richard B ^b   Duley, Lelia ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b KEELE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ANTAGONIST; MAGNESIUM SULFATE; NEUROMUSCULAR BLOCKING AGENT; PHENYTOIN;

ANTICONVULSANT ACTIVITY; ANTIHYPERTENSIVE THERAPY; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; ECLAMPSIA; FEMALE; FETOMATERNAL TRANSFUSION; FETOPLACENTAL UNIT; FETUS MORTALITY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; META ANALYSIS; MUSCLE WEAKNESS; NEUROMUSCULAR BLOCKING; PARALYTIC ILEUS; PLASMA VOLUME; PREECLAMPSIA; PRIORITY JOURNAL; RESPIRATORY ARREST; REVIEW; SEIZURE; SKIN MANIFESTATION;

EID: 0029833635     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199615030-00004     Document Type: Review

References (115)

1. Royston E, Armstrong S. Causes of maternal death. In: Royston E, Armstrong S, editors. Preventing maternal deaths. Geneva: World Health Organization, 1989: 75-106
2. Department of Health and Social Security. Report on confidential enquiries into maternal deaths 1979-1981. London: HMSO, 1986. (Report on Health and Social Subjects; 29)
3. Department of Health and Social Security Report on confidential enquiries into maternal deaths 1982-1984. London: HMSO, 1989. (Report on Health and Social Subjects; 34)
4. Department of Health and Social Security. Report on confidential enquiries into maternal deaths 1985-1987. London: HMSO, 1991
5. Department of Health and Social Security. Report on confidential enquiries into maternal deaths 1988-1990. London: HMSO, 1994
6. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Latin America and the Caribbean. Br J Obstet Gynaecol 1992; 99: 547-53
7. Anthony J, Johanson R, Dommisse J. Critical care management of severe pre-eclampsia. Fet Mat Med Rev 1994; 6: 219-29
8. Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-4
9. McCarthy AL, Woolfson RG, Raju SK, et al. Abnormal endothelial cell function of resistanee arteries from women with preeclampsia. Am J Obstet Gynecol 1993; 168 (4): 323-30
10. Robertson WB, Brosens I, Dixon HG. The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol 1967; 93: 581-92
11. Gant NF, Chand S, Whalley PJ, et al. The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet Gynecol 1974; 43: 854-8
12. Davey DA, MacGillivray I. The classification of the hypertensive disorders of pregnancy. Part B: hypertension in pregnancy. Clin Exp Hypertens 1986; 135 (1): 97-133
13. Halligan A, Bonnar J, Sheppard B, et al. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and preeclampsia. Br J Obstet Gynaecol 1994; 101 (6): 488-92
14. Anthony J, Johanson R. Critical care in pregnancy. Curr Opin Obstet Gynaecol. In press
15. Donaldson JO. The brain in eclampsia. Hypertens Preg 1994; 13 (2); 115-33
16. Richards AM, Graham DI, Bullock MRR. Clinicopathological study of neurological complications due to hypertensive disorders in pregnancy. J Neurosurg Psychiatry 1988; 51: 416
17. Spargo BH, McCartney C, Winemiller R. Glomerular capillary endotheliosus in toxemia of pregnancy. Arch Pathol 1959; 13: 593-9
18. Visser W, Wallenburg HCS. Central hemodynamic observations in untreated preeclamptic patients. Hypertension 1991; 17: 1072-7
19. Belfort MA, Anthony J, Saade GR, et al. The oxygen consumption/oxygen delivery curve in severe pre-eclampsia: evidence for a fixed oxygen extraction state. Am J Obstet Gynecol 1993; 169: 1448-55
20. Milliez J, Dahoun A, Boudraa M. Computed tomography of the brain in eclampsia. Obstet Gynecol 1990; 75: 975-80
21. Trommer RL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke 1988; 19: 326-9
22. Belfort MA, Saade GR. Retinal vasospasm associated with visual disturbance in pre-eclampsia: color flow doppler findings. Am J Obstet Gynecol 1993; 169 (3): 523-5
23. Wallenburg HCS. Hemodynamics in hypertensive pregnancy. In: Rubin PC, editor. Handbook of hypertension: hypertension in pregnancy. Vol 10. Oxford: Elsevier, 1988: 66-101
24. Belfort MA, Saade GR, Wasserstrum N, et al. Acute volume expansion with colloid increases oxygen delivery and consumption but does not improve the oxygen extraction in severe pre-eclampsia. J Mat Fet Med 1995; 4: 57-64
25. Belfort MA, Anthony J, Kirshon B. Respiratory function in severe gestational proteinuric hypertension: the effects of rapid volume expansion and subsequent vasodilatation with verapamil. Br J Obstet Gynaecol 1991; 98: 964-72
26. Duley L. Calcium channel blockers in pregnancy hypertension In: Enkin MW, Kierse MJNC, Renfrew MJ, et al, editors. Pregnancy and childbirth module. Oxford: Published through Cochrane Updates on Disk, Update Software, 1995 Cochrane Database of Systematic Reviews: Review No 07075, 1992 Jul 30
27. Moore MP, Redman CWG. Hypertension in pregnancy. In: Bonnar J, editor. Recent advances in obstetrics and gynaecology. London: Churchill Livingstone, 1987: 20-1
28. Slater RM, Wilcox FL, Smith WD, et al. Phenytoin infusion in severe pre-eclampsia. Lancet 1987; 1: 1417-21
29. Lean TH, Ratnam SS, Sivasanboo R. Use of benzodiazepines in the management of eclampsia. J Obstet Gynaecol Br Commonw 1968; 75: 856-62
30. Ruoss C. The management of eclampsia and severe pre-eclampsia with diazepam and dihydralazinc. S Afr Med J 1974; 48: 1459-60
31. Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol 1984; 148: 951-63
32. Donaldson JO. Does magnesium sulfate treat eclamptic convulsions? Clin Neuropharmacol 1986; 9: 37-45
33. Kaplan PW, Lesser RP, Fisher RS, et al. No, magnesium sulfate should not be used in treating eclamptic seizures. Arch Neurol 1988; 45: 1361-4
34. Eclampsia Trial Collaborative Group. Which anticonvulsant tor women with eclampsia? Evidence from the Collaborative Eclampsia Trial 1995. Lancet 1995; 345: 1455-63
35. Reinhart RA. Clinical correlates of the molecular and cellular actions of magnesium on the cardiovascular system. Am Heart J 1991; 121: 1513-21
36. Sheehan JP, Seelig MS. Interactions of magnesium and potassium in the pathogenesis of cardiovascular disease. Magnesium 1984; 3: 301-14
37. Arsenian MA. Magnesium and cardiovascular disease. Prog Cardiovasc Dis 1993; 35 (4): 271-310
38. Mordes JP, Wacker WC. Excess magnesium. Pharmacol Rev 1978; 29: 273-300
39. Seelig MS, Berger AR. Range of normal serum magnesium values. N Engl J Med 1974; 290: 974-5
40. Spatling I, Disch G, Classen H. Magnesium in pregnant women and the newborn. Magnes Res 1989; 2 (4): 271-80
41. Chesley LC. A survey of management and case mortality. In: Chesley LC, editor. Hypertensive disorders in pregnancy. New York: Appleton-Cenlury-Crofts, 1978: 309-40
42. Pritchard JA. The use of the magnesium ion in the management of eclamptogenic toxemias. Surg Gynecol Obstet 1955; 100: 131-40
43. Zuspan FP. Treatment of severe preeclampsia and eclampsia. Clin Obstet Gynecol 1966; 9: 954-72
44. Mizuki J, Tasaka K, Masumoto N, et al. Magnesium sulfate inhibits oxytocin-induced calcium mobilization in human puerperal myometrial cells: possible involvement of intracellular free magnesium concentration. Am J Obstet Gynecol 1993; 169 (1): 134-9
45. Barton JR, Sibai BM, Ahokas RA, et al. Magnesium sulfate therapy in preeclampsia is associated with increased urinary cyclic guanosine monophosphate excretion. Am J Obstet Gynecol 1992; 167
46. Fuentes A, Goldkrand JW. Angiotensin-converting enzyme activity in hypertensive subjects after magnesium sulfate therapy. Am J Obstet Gynecol 1987; 156 (6): 1375-9
47. Sipes SL, Weiner CP, Gellhaus TM, et al. The plasma renin-angiotensin system in pre-eclampsia: effects of magnesium sulfate. Obstet Gynecol 1989; 73 (6): 934-7
48. Mastrogiamnis DS, Kalter CS, O'Brien WF, et al. Effect of magnesium sulfate on plasma endothelin-1 levels in normal and preeclamptic pregnancies. Am J Obstet Gynecol 1992; 167 (6): 1554-9
49. Belfort MA, Moise Jr KJ. Effect of magnesium sulfate on maternal brain flood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol 1942; 67 (3): 661-6
50. Belfort MA, Saade GR, Moise Jr KJ. The effect of magnesium sulfate on maternal retinal blood flow in preeclampsia: a randomized placebo-controlled study. Am J Obstet Gynecol 1992; 167 (6): 1548-53
51. Kulick DL, Hong R, Ryzen E, et al. Electrophy siologic effects ol intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease. Am Heart J 1988; 115 (2): 367-73
52. Altura BT, Altura BM. Interactions of Mg and K on cerebral vessels; aspects in view of stroke. Review of present status and new findings. Magnesium 1984; 3 (4-6): 195-211
53. de Jonge MC, Traber J. Nimodipine: cognition, aging, and degeneration. Clin Neuropharmacol 1993; 16 Suppl. 1: S25-30
54. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-22
55. Smith Jr LG, Burns PA, Schanler RJ. Calcium homeostasis in pregnant women receiving long-term magnesium sulfate therapy for preterm labor. Am J Obstet Gynecol 1992; 167 (1): 45-51
56. Cruikshank DP, Chan GM, Doerrfeld D. Alterations in vitamin D and calcium metabolism with magnesium sulfate treatment of preeclampsia. Am J Obstet Gynecol 1993; 168 (4): 1170-6
57. Ramanathan J, Sibai BM, Pillai R, et al. Neuromuscular transmission studies in preeclamplic women receiving magnesium sulfate. Am J Obstet Gynecol 1988; 158 (1): 40-6
58. Nelson SH, Suresh MS. Magnesium sulfate-induced relaxation of uterine arteries from pregnant and nonpregnant patients. Am J Obstet Gynecol 1991; 164 (1): 1344-50
59. Petersen OB, Shajaa K, Svane D, et al. The effects of dihydralazine, labetalol and magnesium sulphate on the isolated, perfused human placental cotyledon. Br J Obstet Gynaecol 1994; 101 (10): 871-8
60. Hankins GD, Hammond TL, Yeomans ER. Amniotic cavity accumulation of magnesium with prolonged magnesium sulfate tocolysis. J Reprod Med 1991; 36 (6): 446-9
61. Santi MD, Henry GW, Douglas GL. Magnesium sulfate treatment of preterm labor as a cause of abnormal neonatal bone mineralization. J Pediatr Orthop 1994; 14 (2): 249-53
62. Sherer DM. Blunted fetal response to vibroacoustic stimulation associated with maternal intravenous magnesium sulfate therapy. Am J Perinatal 1994; 11 (6): 401-3
63. Peaceman AM, Meyer BA, Thorp JA, et al. The effect of magnesium sulfate tocolysis on the fetal biophysical profile. Am J Obstet Gynecol 1989; 161 (3): 771-4
64. Lin CC, Pielet BW, Poon E, et al. Effect of magnesium sulfate on fetal heart rate variability in preeclamptic patients during labor. Am J Perinatol 1988; 5 (3): 208-13
65. 4 therapy in preeclampsia/eclampsia. Obstet Gynecol 1981; 57: 199-202
66. Pritchard JA. The use of magnesium sulfate in pre-eclampsia/ eclampsia. J Reprod Med 1979; 23: 107-11
67. Zuspan FP. Problems encountered in the treatment of pregnancy-induced hypertension. Am J Obstet Gynecol 1978; 131: 591-7
68. Thurnau GR, Kemp DB, Jarvis A. Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: a preliminary report. Am J Obstet Gynecol 1987; 157 (6): 1435-8
69. Sadeh M, Blatt I, Martonovits G, et al. Treatment of porphyric convulsions with magnesium sulfate. Epilepsia 1991; 32 (5): 712-5
70. Schiermeyer RP, Finkelstein JA. Rapid infusion of magnesium sulfate obviates need for intubation in status asthmaticus. Am J Emerg Med 1994; 12 (2): 164-6
71. Skobeloff EM, Kim D, Spivey WH. Magnesium sulfate for the treatment of bronchospasm complicating acute bronchitis in a four-months-pregnant woman. Ann Emerg Med 1993 22 (8): 1365-7
72. Sharma SK, Bhargava A, Pande JN. Effect of parenteral magnesium sulfate on pulmonary functions in bronchial asthma. J Asthma 1994; 31 (2): 109-15
73. Hays JV, Gilman JK, Rubal BJ. Effect of magnesium sulfate m ventricular rate control in atrial fibrillation. Ann Emerg Med 1994; 24 (1): 61-4
74. Merril JJ, DeWeese G, Wharton JM. Magnesium reversal of digoxin-facililated ventricular rate during atrial fibrillation in the Wolff-Parkinson-While syndrome. Am J Med 1994; 97 (1): 25-8
75. Keren A. Tzivoni D. Torsades de pointes: prevention and therapy. Cardiovasc Drugs Ther 1991; 5 (2): 509-13
76. Tolsa JF, Cotting J, Sekarski N, et al. Magnesium sulphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn. Arch Dis Child Fetal Neonatal Ed 1995; 72 (3): F184-7
77. Abu-Osha YK, Galal O, Manasra K, et al. Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulphate. Arch Dis Child 1992; 67 (1): 31-5
78. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995; 95 (2): 263-9
79. James MF, Huddle KR, Owen AD, et al. Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma in pregnancy. Can J Anaesth 1988; 35 (2): 178-82
80. Allen RW, James MF, Uys PC. Attenuation of the pressor response to tracheal intubation in hypertensive proteinuric pregnant patients by lignocaine, alfentanil and magnesium sulphate. Br J Anaes 1991; 66 (2): 216-23
81. Ashton WB, James MF, Janicki P, et al. Attentuation of the pressor response to tracheal intubation by magnesium sulphate with and without alfentanil in hypertensive proteinuric patients undergoing caesarean section. Br J Anaesth 1991 67 (6): 747-7
82. Cox SM, Sherman ML, Leveno KJ. Randomised investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol 1990; 163: 767-72
83. Cotton DB, Gonik B, Dorman KF. Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulphate. Am J Obstet Gynaecol 1984; 148: 162-5
84. Richards A, Stather-Dunn L, Moodley J. Cardiopulmonary arrest after the administration of magnesium sulphate: a case report. S Afr Med J 1985; 67 (4): 145
85. Swartjes JM, Schutte MF, Bleker OP. Management of eclampsia: cardiopulmonary arrest resulting from magnesium sulfate overdose. Eur J Obstet Gynecol Reprod Biol 1992; 47 (1): 73-5
86. 4. J Reprod Med 1988; 33 (5): 432-5
87. Herpolsheimer A, Brady K, Yancey MK, et al. Pulmonary function of preeclamptic women receiving intravenous magnesium sulfate prophylaxis. Obstet Gynecol 1991; 78 (2): 241-4
88. Digre KB, Varner MW, Schiffman JS. Neuroophthalmologic effects of intravenous magnesium sulfate. Am J Obstet Gynecol 1990; 163 (1): 1848-52
89. Bashuk RG, Krendel DA. Myasthenia gravis presenting as weakness utter magnesium administration. Muscle Nerve 1990; 13 (8): 708-12
90. Sherer DM, Cialone PR, Abramowitz JS, et al. Transient symptomatic subendocardial ischemia during intravenous magnesium sulfate tocolytic therapy. Am J Obstet Gynecol 1992; 166 (1): 33-5
91. Bourgeois FJ, Thiagarajah S, Harbert GM, et al. Profound hypotension complicating magnesium therapy. Am J Obstet Gynecol 1986; 154 (4): 919-20
92. Thorp JM, Katz VL, Campbell D, et al. Hypersensitivity to magnesium sulfate. Am J Obstet Gynecol 1989; 161 (4): 889-90
93. Hill WC, Gill PJ, Katz M. Maternal paralytic ileus as a complication of magnesium sulfate tocolysis. Am J Perinatol 1985; 2 (1): 47-8
94. Kabam JR, Perry SM, Entman S, et al. Effect of magnesium on plasma cholinesterase activity. Am J Obstet Gynecol 1988; 159 (2): 309-11
95. James MF, Schenk PA, van der Veen BW. Priming of pancuronium with magnesium. Br J Anaesth 1991 66 (2): 247-9
96. Fuchs-Buder T, Wilder-Smith OH, Borgeat A, et al. Interaction of magnesium sulphate with vecuronium-induced neuromuscular block. Br J Anaesth 1995; 74 (4): 405-9
97. James MF, Cork RC, Dennet JE. Succinylcholine pretreatment with magnesium sulfate. Anes Analg 1986; 65 (4): 373-6
98. Ben-Ami M, Giladi Y, Shalev E. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol 1994; 101 (3): 262-3
99. Snyder SW, Cardwell MS. Neuromuscular blockade with magnesium sulfate and nifedipine. Am J Obstet Gynecol 1989; 161 (1): 35-6
100. Waisman GD, Mayorga LM, Camera MJ, et al. Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia? Am J Obstet Gynecol 1988; 159 (2): 308-9
101. Bhalla AK, Dhall GI, Dhall K. A safer and more effective treatment regimen for eclampsia. Aust NZ J Obstet Gynaecol 1994; 34 (2): 144-8
102. Skorodin MS, Freeback PC, Yetter B, et al. Magnesium sulfate potentiates several cardiovascular and metabolic actions. Chest 1994; 105 (3): 701-5
103. Ferguson JE, Holbrook RH, Stevenson DK, et al. Adjunctive magnesium sulfate infusion does not alter metabolic changes associated with ritodrine tocolysis. Am J Obstet Gynecol 1987; 156 (1): 103-7
104. Lucas MJ, Leveno KJ, Cunningham FG. A comparison ot magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333 (4): 201-5
105. Rall TW, Schleifer LS. Drugs effective in the therapy of the epilepsies. In: Goodman AG, Rall TW, Nies AS, et al, editors. Goodman and Gilman's Ihe pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 426-44
106. 10ft. Hayes G, Kootsikas ME. Reassessing the lower end of the phenytoin therapeutic range: a review of the literature Ann Pharmacother 1993; 27 (11): 1389-92
107. Hopkins A. Neurological disorders. In: de Swiet M, editor. Medical disorders in obstetric practice. 2nd ed. Oxford: Blackwell Scientific Publications. 1989; 737-46
108. Friedman SA, Lim KH, Baker CA, et al. Phenytoin versus magnesium sulfate in preeclampsia: a pilot study. Am J Perinatol 1993; 10: 233-8
109. Appleton MP, Kuehl TJ, Raebel M, et al. Magnesium sulfate versus phenytoin for seizure prophylaxis in pregnancy-induced hypertension. Am J Obstet Gynecol 1991; 165: 907-13
110. Dommisse J. Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br J Obstet Gynaecol 1990; 97: 104-9
111. Ryan G, Lange IR, Naugler MA. Clinical experience with phenytoin prophylaxis in severe preeclampsia. Am J Obstet Gynecol 1989; 161: 1297-304
112. Duley L. Phenytoin sodium vs magnesium sulphate in eclampsia. In: Enkin MW, Kierse MJNC, Renfrew MJ, et al, editors. Pregnancy and childbirth module of the Cochrane Database of Systematic Reviews, 1995. BMJ Publishing Group: London
113. Buehler BA, Ruo V, Finnel RH. Biochemical and molecular teratology of fetal hydantoin syndrome. Neurol Clin 1994; 12 (4): 741-8
114. Duley L. Magnesium sulphate vs diazepam in eclampsia. In: Enkin MW, Kierse MJNC, Renfrew MJ, et al, editors. Pregnancy and childbirth module of the Cochrane Database of Systematic Reviews, 1995. BMJ Publishing Group: London
115. Crowther C. Magnesium sulphate versus diazepam in the management of eclampsia: a randomised controlled trial. Br J Obstet Gynaecol 1990; 97: 110-7